Skip to main content
What's on Watch Parliament TV
Main navigation
Loading…

Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 5 May 2021
  6. Current session: 12 May 2021 to 21 June 2025
Answer status
Question type
Clear search

Displaying 1 questions Show Answers

|

Question reference: S6W-38071

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Monday, 09 June 2025
  • Current Status: Answered by Jenni Minto on 19 June 2025

To ask the Scottish Government whether the Scottish Medicines Consortium guidance on the use of ritlecitinib for alopecia areata is in alignment with the guidance from the National Institute for Health and Care Excellence (NICE), which states that living with severe alopecia areata can have a profound impact on psychosocial health.